Comparison of different methods of reduction in blood loss in the surgery of the nose.
Phase 4
- Conditions
- Health Condition 1: O- Medical and Surgical
- Registration Number
- CTRI/2024/03/064432
- Lead Sponsor
- Anshu Kumari
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Patients posted for endoscopic sinus surgery with American Society of Anesthesiologists (ASA) Physical status of I or II
and Duration of surgery – 60 mins upto 120 mins.
Exclusion Criteria
Contraindication or hypersensitivity to the use of any of the drugs used in the study
Any known coagulopathy disorder
Body mass index (BMI) more than 30 kg per metre square
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 1.Comparison of the hemodynamics (HR, MAP) at the start and intraoperatively every 15 minutes(mins). <br/ ><br>2.Assessment of the surgical field every 15min by Average Category Scale(ACS). <br/ ><br>3.Measurement of the blood loss in mililiters(ml). <br/ ><br>Timepoint: 1.Comparison of the hemodynamics (HR, MAP) at the start and intraoperatively every 15 minutes(mins). <br/ ><br>2.Assessment of the surgical field every 15min by Average Category Scale(ACS). <br/ ><br>3.Measurement of the blood loss in mililiters(ml). <br/ ><br>
- Secondary Outcome Measures
Name Time Method 1.Intraoperative Esmolol consumption <br/ ><br>2.Emergence time <br/ ><br>3.Recovery time : time to achieve modified Aldrete score=9 <br/ ><br>4.Complications:dental numbness, headache, bradycardia,hypotension <br/ ><br> <br/ ><br>Timepoint: After completion of surgery, after extubation, in the postoperative recovery room.